Skip to content

Non-linear association of blood urea nitrogen with low cognitive performance: Translational evidence from murine models and human population analysis.

Aug 2026 · Experimental Neurology · Vol 406, pp. 115996 · 0 citations
Medicine

TL;DR

Cross-species evidence links BUN to cognitive, with murine data consistent with human low-BUN risk and identifying a significant inverse association between BUN and LCP that plateaued above approximately 12 mg/dL in this older adult cohort in this cohort.

Abstract

Background

Cognitive impairment in Alzheimer's disease (AD) is increasingly recognized as a systemic metabolic disorder, yet early peripheral biomarkers remain elusive. The kidney-brain axis offers a novel perspective, but the association between blood urea nitrogen (BUN) and Cognitive function is poorly understood.

Methods

We integrated murine models (5xFAD vs. wild-type), human NHANES data (n = 3435), and single-cell virtual knockout of the BUN-associated gene GLS in human kidney cells.

Results

5xFAD mice showed early renal histopathological damage and memory deficits; BUN positively correlated with fear memory retention, and reduced BUN in 5xFAD aligned with the low-BUN risk limb of the human non-linear association. In humans, restricted cubic splines revealed a significant inverse association between BUN and low cognitive performance (LCP), with the risk reduction plateauing at BUN levels above approximately 12 mg/dL. Subgroup analyses showed no significant interactions for any of the examined variables, indicating that the inverse association between BUN and LCP was consistent across population strata. Exploratory GLS knockout upregulated mitochondrial oxidative phosphorylation and ROS pathways, providing hypothesis-generating molecular clues.

Conclusions

Cross-species evidence links BUN to cognitive, with murine data consistent with human low-BUN risk and identifying a significant inverse association between BUN and LCP that plateaued above approximately 12 mg/dL in this older adult cohort in this cohort, which should be viewed as exploratory and requires validation in independent prospective cohorts. Virtual GLS knockout suggests a mitochondrial axis. BUN warrants further evaluation as an accessible biomarker for cognitive risk assessment.

View source

Similar papers

Open access Jul 2026

Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains

AD blood‐based biomarker–cognition associations were domain‐differentiated and context‐dependent: Concurrent associations did not reliably indicate associations with cognition 6 years later, and only p‐tau181 showed formal evidence of relative memory‐versus‐executive selectivity.

Deirdre M. O'Shea, James E. Galvin · 0 citations
Open access Oct 2026

A-40: Associations of Alzheimer’s Plasma Biomarkers with Kidney Disease Functioning

Objective: Plasma concentrations of amyloid-beta 42/40 (Aβ42/40) and phosphorylated tau 217 (p-tau217) are now routinely ordered clinically in older adults as proxy markers for brain Aβ pathology in Alzheimer’s disease. Marked kidney impairment in chronic kidney disease (CKD) influences Aβ42/40 and p-tau217 measureme...

Alejandra Woolsey, Jennifer M. Coughlin, Katelyn R. Jenkins et al. · 0 citations
Oct 2026

Association between urinary metabolomics and cognitive performance in Asians with type 2 diabetes.

BackgroundThere is an ongoing quest for novel biomarkers which may serve as therapeutic targets in cognitive impairment, alongside a growing appreciation of urinary metabolomics as a promising non-invasive approach to identify metabolic signature of Alzheimer's disease and other causes of dementia.ObjectiveWe studied w...

Serena Low, Hui-Li Zheng, A. Moh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.